Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biosensor applications to antitachycardia devices.

T J Cohen1, L B Liem

  • 1Cardiology Division, Stanford University Medical Center, California.

Pacing and Clinical Electrophysiology : PACE
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Biosensors can improve antitachycardia devices by distinguishing stable from unstable tachycardias. Integrating physiological parameters like heart pressure and oxygen saturation enhances arrhythmia detection accuracy.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synthetic amyloid beta does not induce a robust transcriptional response in innate immune cell culture systems.

Journal of neuroinflammation·2022
Same author

Million-year lag times in a post-orogenic sediment conveyor.

Science advances·2020
Same author

Hos2p/Set3p deacetylase complex signals secretory stress through the Mpk1p cell integrity pathway.

Eukaryotic cell·2008
Same author

Initial clinical experience with implantable loop recorders.

The Journal of invasive cardiology·2001
Same author

Arrhythmogenic right ventricular dysplasia and the implantable cardioverter-defibrillator: a case report and review of the literature.

The Journal of invasive cardiology·2000
Same author

Successful radiofrequency catheter ablation of a right posterolateral bypass tract in a patient with Wolff-Parkinson-White syndrome after a previous failed ablative procedure: taking the high road.

The Journal of invasive cardiology·2000
Same journal

Dual Coronary Sinus Lead Strategy to Avoid Tricuspid Valve Traversal in Biventricular Pacing.

Pacing and clinical electrophysiology : PACE·2026
Same journal

A Case of Permanent Pacemaker Implantation via the Epicardial Approach Using the 3830 Lead in an 11-Day-Old Neonate (With Follow-Up of the Above Case).

Pacing and clinical electrophysiology : PACE·2026
Same journal

Cryoballoon Versus Radiofrequency Ablation for Persistent Atrial Fibrillation: Meta-Analysis of Randomized Trials.

Pacing and clinical electrophysiology : PACE·2026
Same journal

Tilt Test Duration in Suspected Vasovagal Syncope: Temporal Patterns and Diagnostic Yield in Patients From Central China.

Pacing and clinical electrophysiology : PACE·2026
Same journal

Combined Leadless Pacing and Subcutaneous ICD Therapy in Long QT Syndromes.

Pacing and clinical electrophysiology : PACE·2026
Same journal

Association of Anesthesia Modality With Procedural Parameters and Clinical Outcomes in PVI for Atrial Fibrillation.

Pacing and clinical electrophysiology : PACE·2026
See all related articles

Area of Science:

  • Biomedical Engineering
  • Cardiology
  • Medical Devices

Background:

  • Current arrhythmia detection algorithms struggle to differentiate between stable and unstable tachycardias.
  • This limitation impacts the effectiveness of antitachycardia devices.
  • Biosensor technology offers a potential solution to enhance device performance.

Purpose of the Study:

  • To explore the application of biosensors in antitachycardia devices.
  • To evaluate the integration of various physiological parameters for improved arrhythmia detection.
  • To describe the current status of biosensor-based arrhythmia detection algorithms.

Main Methods:

  • Investigating the use of right heart pressures and impedance in antitachycardia systems.
  • Considering the integration of additional parameters such as oxygen saturation, pre-ejection period, pH, cardiac output, flow, and temperature.
  • Reviewing the development and application of biosensor arrhythmia detection algorithms.

Main Results:

  • Biosensors show promise for enhancing the ability of antitachycardia devices to distinguish between stable and unstable tachycardias.
  • Incorporating physiological data like right heart pressures and impedance can improve detection accuracy.
  • Further integration of parameters like oxygen saturation and cardiac output may offer additional benefits.

Conclusions:

  • Biosensor integration represents a significant advancement for antitachycardia device functionality.
  • Improved differentiation of tachycardia types leads to more effective treatment.
  • The study highlights the potential of multi-parameter biosensing for personalized cardiac arrhythmia management.